Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MONICA Y LO

Allopathic & Osteopathic Physicians Internal Medicine Clinical Cardiac Electrophysiology

NPI
1578772604
CMS profile
298787
Location
LITTLE ROCK, AR

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$29,822.31

84 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $26,010.00 16
Food and Beverage $3,286.93 65
Travel and Lodging $525.38 3

By paying entity

PY2021 · entire year · sorted by reported total

Paying entityAmountRecords
Abbott Laboratories $29,323.37 73
BOSTON SCIENTIFIC CORPORATION $230.18 5
LivaNova USA, Inc. $145.55 1
ATRICURE, INC. $107.04 4
Merck Sharp & Dohme Corporation $16.17 1

Page 2 of 2; records 51–84 of 84 matching records. This page contains 34 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MONICA Y LO

NPI 1578772604 · CMS profile ID 298787

Allopathic & Osteopathic Physicians / Internal Medicine / Clinical Cardiac Electrophysiology

LITTLE ROCK, AR

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–84 of 84 matching records. This page contains 34 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1578772604?year=2021&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MONICA Y LO, NPI 1578772604, CMS profile ID 298787. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–84 of 84 matching records. This page contains 34 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1578772604?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). MONICA Y LO, NPI 1578772604, CMS profile ID 298787. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–84 of 84 matching records. This page contains 34 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1578772604?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
MONICA Y LO, NPI 1578772604, CMS profile ID 298787, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–84 of 84 matching records. This page contains 34 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1578772604?year=2021&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

84 matching records · $29,822.31 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 84 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–84 of 84.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Abbott Laboratories $1,050.0008/05/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833658773 CMS
Abbott Laboratories $1,312.5007/29/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833658761 CMS
Abbott Laboratories $157.1007/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833658785 CMS
Abbott Laboratories $4.0307/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833658751 CMS
Abbott Laboratories $0.8207/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833658753 CMS
Abbott Laboratories $7.3707/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833658755 CMS
Abbott Laboratories $1,575.0007/22/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833658763 CMS
Abbott Laboratories $1,968.7507/22/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833658765 CMS
Abbott Laboratories $2.2007/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833658797 CMS
Abbott Laboratories $141.8407/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833658795 CMS
Abbott Laboratories $1,575.0006/24/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815575797 CMS
Abbott Laboratories $2,100.0006/24/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815575801 CMS
Abbott Laboratories $12.0706/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815573367 CMS
Abbott Laboratories $184.6906/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815568909 CMS
ATRICURE, INC. $34.7006/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 851074883 CMS
Abbott Laboratories $24.5306/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815555139 CMS
Abbott Laboratories $108.1806/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815550901 CMS
Abbott Laboratories $6.9206/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815534473 CMS
Abbott Laboratories $7.4706/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815534479 CMS
Abbott Laboratories $4.9106/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815534483 CMS
ATRICURE, INC. $21.4905/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 851075893 CMS
Abbott Laboratories $124.9005/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815496095 CMS
Abbott Laboratories $149.2905/07/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815631751 CMS
Abbott Laboratories $13.3904/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815596723 CMS
Abbott Laboratories $8.3804/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815482141 CMS
BOSTON SCIENTIFIC CORPORATION $100.1704/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 777545233 CMS
Abbott Laboratories $12.0004/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815459331 CMS
Abbott Laboratories $14.4303/31/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818457199 CMS
Abbott Laboratories $19.2803/26/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818451591 CMS
Abbott Laboratories $23.6203/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818432003 CMS
Abbott Laboratories $393.7502/25/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818424949 CMS
Abbott Laboratories $393.7502/25/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818424951 CMS
Abbott Laboratories $5.5701/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818399271 CMS
ATRICURE, INC. $18.5101/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 851057567 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $16,623.50 65
PY2020 $30,064.43 60
PY2021 $29,822.31 84
PY2022 $27,356.45 166
PY2023 $49,165.41 377
PY2024 $20,372.74 154
PY2025 $17,085.21 53

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $892,697.90 92
PY2024 Principal investigator $566,565.35 54
PY2023 Principal investigator $105,238.02 32
PY2022 Principal investigator $153,909.36 45
PY2021 Principal investigator $336,227.50 20
PY2020 Principal investigator $131,680.63 23

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

92 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Janssen Research & Development, LLC $1,450.00 12/12/2025 Non-covered Recipient Entity
Arkansas Site Mgmt Svc
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175164244
Principal investigator 1 Abbott Laboratories $54,452.50 11/24/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248159940
Principal investigator 1 Janssen Research & Development, LLC $3,281.00 11/19/2025 Non-covered Recipient Entity
Arkansas Site Mgmt Svc
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175164253
Principal investigator 1 Abbott Laboratories $2,770.00 11/07/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06223789--VOLT-AF IDE Clinical Study No dispute reported 06/30/2026 1248142328
Principal investigator 1 Janssen Research & Development, LLC $4,844.00 11/07/2025 Non-covered Recipient Entity
Arkansas Site Mgmt Svc
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175164635
Principal investigator 1 Abbott Laboratories $45,079.00 11/03/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06223789--VOLT-AF IDE Clinical Study No dispute reported 06/30/2026 1248142110
Principal investigator 1 Abbott Laboratories $1,216.00 10/29/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT05997446--Amulet ADVANCE LAA No dispute reported 06/30/2026 1248158776
Principal investigator 1 Abbott Laboratories $101.00 10/07/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT06223789--VOLT-AF IDE Clinical Study No dispute reported 06/30/2026 1248141982
Principal investigator 1 Janssen Research & Development, LLC $3,726.00 09/19/2025 Non-covered Recipient Entity
Arkansas Site Mgmt Svc
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175164554
Principal investigator 1 Janssen Research & Development, LLC $2,116.00 08/25/2025 Non-covered Recipient Entity
Arkansas Site Mgmt Svc
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175164452
Principal investigator 1 Abbott Laboratories $72,087.35 08/18/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248155654
Principal investigator 1 Abbott Laboratories $33,277.00 08/11/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06223789--VOLT-AF IDE Clinical Study No dispute reported 06/30/2026 1248141652
Principal investigator 1 Abbott Laboratories $1,566.00 08/06/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT05997446--Amulet ADVANCE LAA No dispute reported 06/30/2026 1248155216
Principal investigator 1 Abbott Laboratories $5,950.00 07/31/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06223789--VOLT-AF IDE Clinical Study No dispute reported 06/30/2026 1248141626
Principal investigator 1 Janssen Research & Development, LLC $3,358.00 07/23/2025 Non-covered Recipient Entity
Arkansas Site Mgmt Svc
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175164222
Principal investigator 1 Abbott Laboratories $792.00 07/03/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT06223789--VOLT-AF IDE Clinical Study No dispute reported 06/30/2026 1248141396
Principal investigator 1 Abbott Laboratories $169.00 06/24/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248152004
Principal investigator 1 Abbott Laboratories $188,824.08 06/23/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248151968
Principal investigator 1 Janssen Research & Development, LLC $1,242.00 06/23/2025 Non-covered Recipient Entity
Arkansas Site Mgmt Svc
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175164519
Principal investigator 1 Janssen Research & Development, LLC $2,330.00 06/20/2025 Non-covered Recipient Entity
Arkansas Site Mgmt Svc
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175164331
Principal investigator 1 Abbott Laboratories $101.00 06/12/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248151818
Principal investigator 1 Abbott Laboratories $624.00 06/12/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248151840
Principal investigator 1 Abbott Laboratories $169.00 06/05/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248151568
Principal investigator 1 Abbott Laboratories $624.00 06/05/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248151606
Principal investigator 1 Abbott Laboratories $2,090.00 05/29/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT05997446--Amulet ADVANCE LAA No dispute reported 06/30/2026 1248151354
Principal investigator 1 Janssen Research & Development, LLC $4,968.00 05/21/2025 Non-covered Recipient Entity
Arkansas Site Mgmt Svc
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175164703
Principal investigator 1 Abbott Laboratories $26,554.00 04/23/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06223789--VOLT-AF IDE Clinical Study No dispute reported 06/30/2026 1248140990
Principal investigator 1 Abbott Laboratories $753.00 04/15/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT06223789--VOLT-AF IDE Clinical Study No dispute reported 06/30/2026 1248140850
Principal investigator 1 Abbott Laboratories $169.00 04/15/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT06223789--VOLT-AF IDE Clinical Study No dispute reported 06/30/2026 1248140916
Principal investigator 1 Abbott Laboratories $7,000.00 04/14/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248149022
Principal investigator 1 Abbott Laboratories $7,000.00 04/14/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248152484
Principal investigator 1 Abbott Laboratories $7,000.00 04/08/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248149010
Principal investigator 1 Abbott Laboratories $7,000.00 04/08/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248152486
Principal investigator 1 Abbott Laboratories $7,000.00 04/07/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248149020
Principal investigator 1 Abbott Laboratories $7,000.00 04/07/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248152480
Principal investigator 1 Abbott Laboratories $5,580.00 04/01/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06223789--VOLT-AF IDE Clinical Study No dispute reported 06/30/2026 1248140474
Principal investigator 1 Abbott Laboratories $1,972.00 04/01/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT06223789--VOLT-AF IDE Clinical Study No dispute reported 06/30/2026 1248140680
Principal investigator 1 Abbott Laboratories $5,580.00 04/01/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06223789--VOLT-AF IDE Clinical Study No dispute reported 06/30/2026 1248140734
Principal investigator 1 Abbott Laboratories $7,000.00 04/01/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248149006
Principal investigator 1 Abbott Laboratories $7,000.00 04/01/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248149008
Principal investigator 1 Abbott Laboratories $7,000.00 04/01/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248152478
Principal investigator 1 Abbott Laboratories $7,000.00 04/01/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248152482
Principal investigator 1 Abbott Laboratories $7,000.00 03/31/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248149002
Principal investigator 1 Abbott Laboratories $7,000.00 03/31/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248149004
Principal investigator 1 Abbott Laboratories $7,000.00 03/27/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248149000
Principal investigator 1 Abbott Laboratories $32,917.75 03/26/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248147840
Principal investigator 1 Janssen Research & Development, LLC $6,146.00 03/21/2025 Non-covered Recipient Entity
Arkansas Site Mgmt Svc
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175164444
Principal investigator 1 Abbott Laboratories $7,000.00 03/18/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248148998
Principal investigator 1 Abbott Laboratories $792.00 03/11/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248147524
Principal investigator 1 Abbott Laboratories $58.10 03/05/2025 Non-covered Recipient Entity
MPX Group
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248147312
Principal investigator 1 Abbott Laboratories $7,000.00 03/04/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248148996
Principal investigator 1 Abbott Laboratories $7,000.00 02/26/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248148992
Principal investigator 1 Abbott Laboratories $7,000.00 02/26/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248148994
Principal investigator 1 Abbott Laboratories $58,646.00 02/24/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06223789--VOLT-AF IDE Clinical Study No dispute reported 06/30/2026 1248140416
Principal investigator 1 Abbott Laboratories $159.00 02/21/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT06223789--VOLT-AF IDE Clinical Study No dispute reported 06/30/2026 1248140366
Principal investigator 1 Abbott Laboratories $427.00 02/21/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248146800
Principal investigator 1 Abbott Laboratories $18.98 02/21/2025 Non-covered Recipient Entity
MPX Group
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248146910
Principal investigator 1 Abbott Laboratories $60.00 02/21/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248147952
Principal investigator 1 Abbott Laboratories $7,000.00 02/21/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248148984
Principal investigator 1 Abbott Laboratories $7,000.00 02/21/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248148986
Principal investigator 1 Abbott Laboratories $7,000.00 02/21/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248148988
Principal investigator 1 Abbott Laboratories $7,000.00 02/21/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248148990
Principal investigator 1 Janssen Research & Development, LLC $3,851.00 02/19/2025 Non-covered Recipient Entity
Arkansas Site Mgmt Svc
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175164391
Principal investigator 1 Abbott Laboratories $7,000.00 02/18/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248148982
Principal investigator 1 Abbott Laboratories $7,000.00 02/17/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248148978
Principal investigator 1 Abbott Laboratories $7,000.00 02/17/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248148980
Principal investigator 1 Abbott Laboratories $45.00 02/11/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248147950
Principal investigator 1 Abbott Laboratories $7,000.00 02/11/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248148970
Principal investigator 1 Abbott Laboratories $7,000.00 02/11/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248148972
Principal investigator 1 Abbott Laboratories $7,000.00 02/11/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248148974
Principal investigator 1 Abbott Laboratories $7,000.00 02/11/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248148976
Principal investigator 1 Abbott Laboratories $7,000.00 02/10/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248148966
Principal investigator 1 Abbott Laboratories $7,000.00 02/10/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248148968
Principal investigator 1 Abbott Laboratories $7,000.00 02/04/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248148962
Principal investigator 1 Abbott Laboratories $7,000.00 02/04/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248148964
Principal investigator 1 Abbott Laboratories $7,000.00 01/30/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248148960
Principal investigator 1 Abbott Laboratories $792.00 01/29/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248144994
Principal investigator 1 Abbott Laboratories $7,000.00 01/29/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248148958
Principal investigator 1 Abbott Laboratories $7,000.00 01/28/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248148952
Principal investigator 1 Abbott Laboratories $7,000.00 01/28/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248148954
Principal investigator 1 Abbott Laboratories $7,000.00 01/28/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248148956
Principal investigator 1 Abbott Laboratories $7,000.00 01/27/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248148950
Principal investigator 1 Abbott Laboratories $19.14 01/24/2025 Non-covered Recipient Entity
MPX Group
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248144904
Principal investigator 1 Abbott Laboratories $7,000.00 01/23/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248148948
Principal investigator 1 Abbott Laboratories $1,075.00 01/22/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT05997446--Amulet ADVANCE LAA No dispute reported 06/30/2026 1248144986
Principal investigator 1 Abbott Laboratories $7,000.00 01/22/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248148946
Principal investigator 1 Janssen Research & Development, LLC $1,801.00 01/22/2025 Non-covered Recipient Entity
Arkansas Site Mgmt Svc
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175164527
Principal investigator 1 Abbott Laboratories $75.00 01/17/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248147948
Principal investigator 1 Abbott Laboratories $7,000.00 01/16/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248149016
Principal investigator 1 Abbott Laboratories $7,000.00 01/16/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248149018
Principal investigator 1 Abbott Laboratories $7,000.00 01/14/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248149012
Principal investigator 1 Abbott Laboratories $7,000.00 01/14/2025 Non-covered Recipient Entity
Arkansas Site Management Services
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248149014